MJRIC
Mogy Joel R Investment Counsel Portfolio holdings
AUM
$1.73B
This Quarter Return
+6.95%
1 Year Return
+20.32%
3 Year Return
+125.21%
5 Year Return
+189.43%
10 Year Return
+523.77%
AUM
$533K
AUM Growth
+$533K
(-100%)
Cap. Flow
-$13.4M
Cap. Flow
% of AUM
-2,520.16%
Top 10 Holdings %
Top 10 Hldgs %
34.13%
Holding
136
New
5
Increased
–
Reduced
122
Closed
9
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$12.1K |
| 2 |
Air Lease Corp
AL
|
$238 |
| 3 |
Dentsply Sirona
XRAY
|
$231 |
| 4 |
Norfolk Southern
NSC
|
$216 |
| 5 |
Illinois Tool Works
ITW
|
$204 |
Top Sells
| 1 |
TYG
Tortoise Energy Infrastructure Corp
TYG
|
$3.94M |
| 2 |
Chipotle Mexican Grill
CMG
|
$1.47M |
| 3 |
RTX Corp
RTX
|
$1.01M |
| 4 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
$773K |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
$470K |
Sector Composition
| 1 | Technology | 19.18% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Communication Services | 12.86% |
| 5 | Consumer Staples | 11.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Accenture
ACN
$162B
| $7.68K | 1.44% |
7,350
-57,625
| -89% | -$60.2K |
|
27
Amazon
AMZN
$2.44T
| $7.68K | 1.44% |
1,136
-9,799
| -90% | -$66.3K |
|
28
Gilead Sciences
GILD
$140B
| $7.33K | 1.38% |
7,246
-59,844
| -89% | -$60.6K |
|
29
AT&T
T
$209B
| $7.11K | 1.33% |
20,668
-170,249
| -89% | -$58.6K |
|
30
Union Pacific
UNP
$133B
| $6.93K | 1.3% |
8,863
-77,378
| -90% | -$60.5K |
|
31
Nike
NKE
$114B
| $6.62K | 1.24% |
10,587
-40,500
| -79% | -$25.3K |
|
|
AGN
32
DELISTED
Allergan plc
AGN
| $6.61K | 1.24% |
2,115
-15,646
| -88% | -$48.9K |
|
33
Henry Schein
HSIC
$8.44B
| $6.1K | 1.14% |
3,857
-33,513
| -90% | -$53K |
|
34
GE Aerospace
GE
$292B
| $6.06K | 1.14% |
19,443
-196,946
| -91% | -$61.4K |
|
35
Philip Morris
PM
$260B
| $4.71K | 0.88% |
5,362
-48,163
| -90% | -$42.3K |
|
36
Pfizer
PFE
$141B
| $4.41K | 0.83% |
13,675
-132,379
| -91% | -$42.7K |
|
37
Meta Platforms (Facebook)
META
$1.86T
| $4.33K | 0.81% |
4,138
-23,612
| -85% | -$24.7K |
|
38
AbbVie
ABBV
$372B
| $4.32K | 0.81% |
7,296
-65,470
| -90% | -$38.8K |
|
39
Intel
INTC
$107B
| $4.31K | 0.81% |
12,513
-112,618
| -90% | -$38.8K |
|
40
Altria Group
MO
$113B
| $4.16K | 0.78% |
7,148
-64,362
| -90% | -$37.5K |
|
41
Simon Property Group
SPG
$59B
| $4.16K | 0.78% |
2,139
-19,560
| -90% | -$38.1K |
|
42
Idexx Laboratories
IDXX
$51.8B
| $3.75K | 0.7% |
5,140
-47,515
| -90% | -$34.6K |
|
43
T Rowe Price
TROW
$23.6B
| $3.62K | 0.68% |
5,060
-47,140
| -90% | -$33.7K |
|
44
Abbott
ABT
$231B
| $3.17K | 0.59% |
7,046
-63,420
| -90% | -$28.5K |
|
45
Palo Alto Networks
PANW
$127B
| $3.14K | 0.59% |
1,783
-8,997
| -83% | -$15.8K |
|
46
Mondelez International
MDLZ
$79.5B
| $2.97K | 0.56% |
6,628
-55,858
| -89% | -$25K |
|
47
IBM
IBM
$227B
| $2.9K | 0.54% |
2,109
-19,037
| -90% | -$26.2K |
|
48
Chevron
CVX
$324B
| $2.8K | 0.52% |
3,110
-30,181
| -91% | -$27.2K |
|
49
Merck
MRK
$210B
| $2.75K | 0.51% |
5,196
-47,064
| -90% | -$24.9K |
|
50
Schlumberger
SLB
$55B
| $2.57K | 0.48% |
3,679
-34,067
| -90% | -$23.8K |
|